Cancer Innovation

SJR Rank #5,573H-index: 13SJR: 0.921Best quartile: Q1Open AccessAPC: US$2,700Listed in DOAJ
Publisher

John Wiley and Sons Inc

Country

United States

Type

journal

SJR by Edition

Only one SJR edition is available for this journal so far.

Subject Categories

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1
  • Drug DiscoveryQ2
  • OncologyQ2
  • Pharmacology (medical)Q2
  • Cancer ResearchQ3

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Cancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesFerroptosis and cancer prognosisHER2/EGFR in Cancer ResearchDiverse Scientific and Economic StudiesHuman auditory perception and evaluationEducational Robotics and EngineeringLung Cancer Research StudiesAdvanced Breast Cancer TherapiesRadiomics and Machine Learning in Medical Imaging

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03570105140

Documents per Year

Only one SJR edition is available for this journal so far.

Detailed Information

ISSN

2770-9191, 2770-9183

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

3.78

References per Document

61.18

Coverage

2022-2026

Scope

No scope description available yet.

Metrics from SCImago Journal Rank 2025. View on SCImago